Similar articles

• Evidence-Based Guidelines to Eliminate Repetitive Laboratory Testing.

  Eaton KP, Levy K, Soong C, Pahwa AK, Petrilli C, Ziemba JB, Cho HJ, Alban R, Blanck JF, Parsons AS. Eaton KP, et al. JAMA Intern Med. 2017 Dec 1;177(12):1833-1839. doi: 10.1001/jamainternmed.2017.5152. JAMA Intern Med. 2017. PMID: 29049500 Review.
• Evidence-Based Guidelines to Eliminate Repetitive Laboratory Testing?

  Bindraban RS, Ten Berg MJ, Naaktgeboren CA. Bindraban RS, et al. JAMA Intern Med. 2018 Mar 1;178(3):431. doi: 10.1001/jamainternmed.2017.8522. JAMA Intern Med. 2018. PMID: 29507978 No abstract available.
• Finnish guidelines for workplace drug testing.

  Lillsunde P, Haavanlammi K, Partinen R, Mukala K, Lamberg M. Lillsunde P, et al. Forensic Sci Int. 2008 Jan 30;174(2-3):99-102. doi: 10.1016/j.forsciint.2007.03.006. Epub 2007 May 17. Forensic Sci Int. 2008. PMID: 17499950
• Critical review of 2016 ACC guidelines on therapies for cholesterol lowering with reference to laboratory testing.

  Levinson SS. Levinson SS. Clin Chim Acta. 2019 Feb;489:189-195. doi: 10.1016/j.cca.2017.11.001. Epub 2017 Nov 6. Clin Chim Acta. 2019. PMID: 29104037 Review.
• Reply: getting guidelines correct: their evidence-based recommendations for use of nonstatins added to statins and the need for follow-up lipid testing.

  Maddox TM, Oetgen WJ, Rumsfeld JS. Maddox TM, et al. J Am Coll Cardiol. 2015 May 12;65(18):2052-3. doi: 10.1016/j.jacc.2015.02.057. J Am Coll Cardiol. 2015. PMID: 25953758 No abstract available.